However, oral weight-loss medications do exist: oral Wegovy (semaglutide) was approved in late 2025, and Foundayo (orforglipron), an oral GLP-1 pill from Eli Lilly, was FDA-approved in April 2026
Scintigraphic images showed that no erosion had occurred 2 min after dosing, whereas no intact tablet core remained after 140 min
Individuals taking medications, managing health conditions, or who are pregnant or nursing are appropriately evaluated by qualified healthcare professionals when considering GLP-1 medications
Diabetes was identified using ICD-10-CM codes (E11.44, E11.8, E11.649, E11.65, E11.9) during the baseline period, while OSA was diagnosed in both cohorts during follow-up using ICD-10-CM codes M15, M16, M17, M18, and M19
A journal article in The Journal of the Endocrine Society featured the case of a 31-year-old female with obesity who bought semaglutide from a compounding pharmacy and injected the drug incorrectly at 2.5mg/0.5mL, ten times the amount prescribed
Both are now available in India by prescription
